Tocilizumab : Tocilizumab: The first interleukin-6-receptor inhibitor

Anlotinib : Anlotinib induces hepatocellular carcinoma apoptosis and inhibits proliferation via Erk and Akt pathway

Necrostatin 2 : FADD-deficient mouse embryonic fibroblasts undergo RIPK1-dependent apoptosis and autophagy after NB-UVB irradiation